Skip to main content
Contact us

EMA EU GMP CDMO Companies
European Pharmaceutical Manufacturing Services

Your Trusted Partners for European Pharmaceutical Manufacturing and Development

Applied Filters:EMA (EU GMP)×Clear All
Showing 137 facilities
Ophtapharm AG
Switzerland

Ophtapharm AG

Ophtapharm, a Sentiss Company

MARKETS: EMA (EU), FDA (USA), Russian Health Authorities, MFDS (South Korea)

COMPLIANCE: FDA (cGMP), EMA (EU GMP)

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

REGION: Europe

HIPRA BIOTECH SERVICES | Aiguaviva
Spain

HIPRA BIOTECH SERVICES | Aiguaviva

HIPRA Biotech Services

End-to-end internal capabilities from cell line development to commercial manufacturing.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BSL (Biological Safety Level): 1, 2

USE: Human

BATCH SIZE: Large, Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

REGION: Europe

CATEGORY / PRODUCT: BIOLOGICS

Adare Pharma | EU
Italy

Adare Pharma | EU

Adare Pharma Solutions

Global CDMO offering turnkey product development through commercial manufacturing expertise, focused on oral dosage forms.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), TGA (Australia)

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Halal Research Council, ECOVADIS, TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, French Service-Public (CIR), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (N) Nervous system, (J) Antiinfectives for systemic use, (V01) Allergens, (R) Respiratory system, (M) Musculoskeletal system, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING, SERVICES

REGION: Europe

CZ Vaccines | Large Scale Plant Portugal
Portugal

CZ Vaccines | Large Scale Plant Portugal

CZ Vaccines

Commercial Scale Facility

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU)

COMPLIANCE: ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

BSL (Biological Safety Level): 1, 2

USE: Human

BATCH SIZE: Large, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use, (R) Respiratory system, (G) Genito urinary system and sex hormones

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, BIOLOGICS

REGION: Europe

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes
Spain

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes

HISTOCELL

Histocell is a Spanish CDMO that develops and manufactures cell therapies, secretomes and exosomes, as well medical devices.

SERVICES: Development services, Analytical / QC services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), CDSCO (India), TGA (Australia)

COMPLIANCE: ISO, EMA (EU GMP)

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: COSMETICS, FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (C) Cardiovascular system, (A) Digestive tract and metabolism

BATCH SIZE: Small, Medium

REGION: Europe

Adare Pharma | US
United States

Adare Pharma | US

Adare Pharma Solutions

Adare Pharma es un CDMO global con instalaciones en EE.UU. y la UE, que ofrece desarrollo de productos llave en mano mediante experiencia en fabricación comerci

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), TGA (Australia)

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Halal Research Council, ECOVADIS, TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, French Service-Public (CIR), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING, SERVICES

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (A) Digestive tract and metabolism

REGION: North America

FAES FARMA | DERIO facility
Spain

FAES FARMA | DERIO facility

FAES FARMA

Developer and manufacturer of human medicinal products.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), EDE (UAE), TGA (Australia)

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), French Service-Public (CIR), NMPA (China GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

USE: Human

BATCH SIZE: Large, Small, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (N) Nervous system, (J) Antiinfectives for systemic use, (D) Dermatologicals, (R) Respiratory system, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

REGION: Europe

Laboratorios Grifols | Murcia Plant
Spain

Laboratorios Grifols | Murcia Plant

Grifols International

Sterile manufacturing solutions (small molecules) in flexible bags.

MARKETS: EMA (EU), FDA (USA), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

SERVICES: Logistics, Analytical / QC services, Packaging, Quality Assurance services, Manufacturing services

CONTROLLED SUBSTANCES: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse

THERAPEUTIC AREAS OF EXPERTISE (ATC): (N) Nervous system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

REGION: Europe

Cenexi
France

Cenexi

Cenexi

GMP plant on a four-hectare site is located 9 km east of Paris. It is a center of excellence for injectable ampoules.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), EDE (UAE), TGA (Australia)

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

CONTROLLED SUBSTANCES: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Low potential for abuse

THERAPEUTIC AREAS OF EXPERTISE (ATC): (N) Nervous system, (J) Antiinfectives for systemic use, (D) Dermatologicals, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

REGION: Europe

Adragos Pharma | Kawagoe
Japan

Adragos Pharma | Kawagoe

Adragos Pharma

Our facility provides best-in-class manufacturing of tablets and ampoules.

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), EMA (EU GMP)

USE: Human

BATCH SIZE: Large

SERVICES: Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

CONTROLLED SUBSTANCES: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & medical use, Low potential for abuse

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES

REGION: APAC

Nexora Cell and Tissue Therapy Manufacturing Site
Germany

Nexora Cell and Tissue Therapy Manufacturing Site

Green Phoenix Labs GmbH

Licensed ATMP site in Germany. GMP manufacturing and QP batch release for cell and tissue therapies.

SERVICES: Development services, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU)

BSL (Biological Safety Level): 1, 2

USE: Human

CONTROLLED SUBSTANCES: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse

THERAPEUTIC AREAS OF EXPERTISE (ATC): (S) Sensory organs, (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

BATCH SIZE: Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

COMPLIANCE: EMA (EU GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

REGION: Europe

HIPRA BIOTECH SERVICES | Amer
Spain

HIPRA BIOTECH SERVICES | Amer

HIPRA Biotech Services

End-to-end internal capabilities from cell line development to commercial manufacturing.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BSL (Biological Safety Level): 1, 2

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, BIOLOGICS

REGION: Europe

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+69 more facilities

Create free account

To succeed in the European pharmaceutical market, companies must meet the rigorous quality and regulatory expectations set by the European Medicines Agency (EMA). That’s why pharma and biotech companies partner with experienced EMA EU GMP CDMO companies to ensure their products are developed and manufactured in full compliance with European pharmaceutical manufacturing standards.

With EMA-certified facilities, robust quality systems, and global submission support, these CDMOs help bring your product to EU and international markets safely and efficiently.

How to Choose EMA EU GMP CDMO Companies

When selecting EMA EU GMP CDMO companies, consider:

Verifying compliance credentials with EU-GMP certification: Issued by national regulatory authorities in the EU.

Ensuring global audit readiness via Successful EMA inspections: And audit readiness for global compliance.

Supporting clinical-to-market transitions with Experience with both clinical and commercial-scale manufacturing: Covering all development phases.

Establishing robust batch oversight through Proven quality systems: In line with ICH Q7/Q8/Q10 standards.

Streamlining regulatory filings via Support for EU submissions: MAA, CEP, IMPD, and ASMF documentation.

Enabling batch release in Europe through Pharmacovigilance and Qualified Person (QP) release capabilities: Meeting EEA requirements.

Leveraging strategic regional infrastructure via Facility location within the European Economic Area (EEA): Facilitating European supply chain efficiency.

The right CDMO ensures your project meets both technical and regulatory requirements for entry into the European market.

Key Services Offered by European Pharmaceutical Manufacturing Partners

Top-tier European pharmaceutical manufacturing providers typically offer:

Optimizing solid and liquid processes via GMP formulation development and process optimization: Designed for scale and stability.

Manufacturing diverse active ingredients and finished products, including Manufacturing of oral solids, liquids, injectables, biologics, and APIs: Across multiple dosage forms.

Verifying product specifications with Analytical testing and EU-compliant documentation: Supporting quality control requirements.

Processing sterile and non-sterile formats through Sterile and non-sterile fill-finish capabilities: In compliant cleanroom suites.

Facilitating commercial market entry via Batch certification and QP release for clinical and commercial supply: Ensuring EU market authorization compliance.

Assisting clinical trial approvals through Support for EU submissions: Including IMPDs and CTAs.

Executing smooth scale-up operations via Technology transfer, scale-up, and process validation: Minimizing technical risks.

Securing end-to-end tracebility with Packaging and serialization according to EU FMD regulations: Preventing falsified medicines.

These services ensure full regulatory alignment and market readiness for EU and global supply.

Advantages of Partnering with EMA EU GMP CDMO Companies

Collaborating with experienced EMA EU GMP CDMO companies offers major advantages:

Securing European market entry via EU market access: Via compliant manufacturing and QP certification.

Achieving international health authority trust with Global regulatory acceptance: Supported by high EMA quality standards.

Preventing regulatory disruptions through Reduced risk of delays or rejections: Due to audit-proven processes.

Formulating novel biopharmaceuticals with Support for complex drug formats and emerging therapies: Including cell and gene therapies.

Streamlining overall operations via Seamless integration: Of development, manufacturing, and submission workflows.

European manufacturing quality is globally recognized — and your CDMO partner should reflect that.

EMA EU GMP CDMO Companies

Some of the most trusted EMA EU GMP CDMO companies include:

CDM Lavoisier: Human drugs CDMO specialized in the manufacturing of glass ampoules, glass vials and plastic (BFS) ampoules. [See CDMO profile]

Cenexi: CDMO that specializes in the production of sterile highly potent injectables, mainly against cancer. [See CDMO profile]

FAES FARMA: Developer and manufacturer of human medicinal products. [See CDMO profile]

ASCIL Biopharm: GMP facility fully equipped for R&D and pharmaceutical development. [See CDMO profile]

Grifols: Sterile manufacturing solutions (small molecules) in flexible bags and vials. [See CDMO profile]

VIVUNT PHARMA: CDMO for sterile oncology drugs. [See CDMO profile]

Liof Pharma: Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs. [See CDMO profile]

Reig Jofre: Injectable (lyo and liquid) and liquid manufacturing facilities. [See CDMO]

Pharmaloop: Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets. [See CDMO profile]

Glatt Pharmaceutical Services GmbH Co. & KG: cGMP-compliant CDMO for end-to-end services in complex oral solid dosage forms. [See CDMO profile]

Adragos Pharma: Over 100 years of experience delivering customer-focused manufacturing and first-class service. [See CDMO profile]

CARBOGEN AMCIS: Highly potent APIs development and small-scale cGMP production including chromatography and lyophilization. [See CDMO profile]

Apeloa Pharmaceutical Co., Ltd: Development and manufacturing of APIs, intermediates and registered starting materials. [See CDMO profile]

Mabion cGMP Facility: Development and GMP manufacturing of biotherapeutics including monoclonal antibodies and recombinant protein products. [See CDMO profile]

Ophtapharm, a Sentiss Company: Ophthalmic and otic solutions, suspensions, emulsions, ointments and gels. FDA-approved facility. [See CDMO profile]

Cellex Cell Professionals: CGT CDMO specialized in cell manufacturing and collection of starting materials. [See CDMO profile]

AdhexPharma SAS: CDMO for transdermal patches and oromucosal films. [See CDMO profile]

MENADIONA S.L: APIs, intermediates and fine chemicals; specialized in transferring R&D projects into full cGMP manufacturing. [See CDMO profile]

Content Group: Tubilux Pharma manufacturing facility. [See CDMO profile]

TRADICHEM INDUSTRIAL SERVICES: HIPERING® technology enabling lean manufacturing. [See CDMO profile]

53Biologics Production Plant: Biologics production from DNA to proteins, from preclinical to cGMP manufacturing. [See CDMO profile]

Rioja Nature Pharma: CDMO specializing in nutraceuticals and food supplements. [See CDMO profile]

HIPRA BIOTECH SERVICES: End-to-end capabilities from cell line development to commercial manufacturing. [See CDMO profile]

Skyepharma: Development and delivery of oral technologies for pharma, biotech and consumer health. [See CDMO profile]

ChemCon GmbH: CDMO for APIs and fine chemicals with expertise in scaling R&D projects to cGMP manufacturing. [See CDMO profile]

VIVEbiotech: GMP-certified CDMO dedicated to lentiviral vector production. [See CDMO profile]

BAG Health Care: Parenteral fill & finish for vials in small to mid-size batches and investigational products. [See CDMO profile]

Lannett CDMO: OSD and liquid manufacturing capabilities in Seymour, Indiana. [See CDMO profile]

Basic Pharma Manufacturing: Analytical testing and regulatory support tailored to project needs. [See CDMO profile]

HISTOCELL S.L: Developer and manufacturer of cell therapies (iPSCs, MSCs, secretomes, exosomes) plus medical devices and dermocosmetics. [See CDMO profile]

Lukas Heil-Betriebsstätte: High-performance GMP facility for sterile and aseptic liquids, especially glass ampoules. [See CDMO profile]

Laboratori Alchemia SRL: Production from lab scale for complex synthetic products to hundreds of kilograms per year. [See CDMO profile]

Cambrex: Specialists in late-phase and commercial API development and cGMP manufacturing. [See CDMO profile]

Aenova Group: Competence center for solids, semisolids, liquids and clinical services. [See CDMO profile]

Pharmaron: Commercial small molecule API synthesis. [See CDMO profile]

Darnytsia Kyiv: Advanced facilities, strict quality control and expert staff for reliable, compliant solutions. [See CDMO profile]

White Raven: Fill & finish site dedicated to GMP formulation and aseptic filling of sterile liquid injectables. [See CDMO profile]

Sidefarma: Specialist in small and medium batch manufacturing for regulated markets following EU quality standards. [See CDMO profile]

Sylentis: Oligonucleotide manufacturer. [See CDMO profile]

These CDMOs combine quality infrastructure with regulatory experience to ensure EU market success.

Related Information

You may also be interested in:

FDF CDMO Services | Finished Dosage Forms Contract Manufacturing

Biologics CDMO Companies | Biopharmaceutical Contract Manufacturing

Chemical CMO companies | Custom Synthesis and Chemical CMO Solutions

FDA cGMP CDMO Companies | FDA Compliant Manufacturing Services

HPAPI CDMO Companies | Highly Potent API Manufacturing Services

Human Drugs CDMO Companies | Human Medicinal Products Contract Manufacturing Services

Let MAI CDMO Help You Find the Right EMA EU GMP CDMO Partner

At MAI CDMO, we connect pharma and biotech companies with the most qualified EMA EU GMP CDMO companies offering world-class European pharmaceutical manufacturing services. Whether you´re preparing for an EU clinical trial, submitting a marketing authorization application, or scaling to commercial supply, we’ll help you find a trusted partner to ensure EU-GMP compliance every step of the way.

Need an EU-compliant manufacturing solution? Contact us today and find your ideal European CDMO partner.